Roivant Sciences (ROIV) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to -$3.8 billion.
- Roivant Sciences' Enterprise Value rose 2031.25% to -$3.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.8 billion, marking a year-over-year increase of 2031.25%. This contributed to the annual value of -$4.4 billion for FY2025, which is 2706.08% up from last year.
- As of Q4 2025, Roivant Sciences' Enterprise Value stood at -$3.8 billion, which was up 2031.25% from -$3.9 billion recorded in Q3 2025.
- In the past 5 years, Roivant Sciences' Enterprise Value ranged from a high of -$1.0 billion in Q2 2023 and a low of -$6.2 billion during Q4 2023
- For the 5-year period, Roivant Sciences' Enterprise Value averaged around -$3.0 billion, with its median value being -$2.0 billion (2021).
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 4248.28% in 2022, then tumbled by 48771.26% in 2023.
- Roivant Sciences' Enterprise Value (Quarter) stood at -$1.8 billion in 2021, then soared by 42.48% to -$1.1 billion in 2022, then crashed by 487.71% to -$6.2 billion in 2023, then grew by 22.65% to -$4.8 billion in 2024, then rose by 20.31% to -$3.8 billion in 2025.
- Its last three reported values are -$3.8 billion in Q4 2025, -$3.9 billion for Q3 2025, and -$4.0 billion during Q2 2025.